Wnt5a regulates multiple intracellular signalling cascades, but how Wnt5a determines the specificity of these pathways is not well understood. This study examined whether the internalization of Wnt receptors affects the ability of Wnt5a to regulate its signalling pathways. Wnt5a activated Rac in the b-catenin-independent pathway, and Frizzled2 (Fz2) and Ror1 or Ror2 were required for this action. Fz2 was internalized through a clathrin-mediated route in response to Wnt5a, and inhibition of clathrindependent internalization suppressed the ability of Wnt5a to activate Rac. As another action of Wnt5a, it inhibited Wnt3a-dependent lipoprotein receptor-related protein 6 (LRP6) phosphorylation and b-catenin accumulation. Wnt3a-dependent phosphorylation of LRP6 was enhanced in Wnt5a knockout embryonic fibroblasts. Fz2 was also required for the Wnt3a-dependent accumulation of b-catenin, and Wnt5a competed with Wnt3a for binding to Fz2 in vitro and in intact cells, thereby inhibiting the b-catenin pathway. This inhibitory action of Wnt5a was not affected by the impairment of clathrin-dependent internalization. These results suggest that Wnt5a regulates distinct pathways through receptor internalizationdependent and -independent mechanisms.
Introduction
Wnt proteins constitute a large family of secreted ligands that control developmental processes in animals (Logan and Nusse, 2004) . In mice and humans, there are 19 Wnt members, which exhibit unique expression patterns and distinct functions in development. Wnts control various cellular functions including proliferation, differentiation, apoptosis, survival, migration, and polarity, by regulating multiple intracellular signalling cascades. In humans and mice, the 10 members of the Frizzled (Fz) seven transmembrane receptor family have been identified as Wnt receptors (Wang et al, 2006) . In addition to Fz proteins, single-pass transmembrane proteins, such as low-density lipoprotein receptor-related protein 5 (LRP5), LRP6, receptor tyrosine kinase-like orphan receptor 1 (Ror1), Ror2, and atypical tyrosine kinase receptor (Ryk), have been shown to act as Wnt receptors (Gordon and Nusse, 2006; Fukuda et al, 2008; Green et al, 2008; Kikuchi et al, 2009) .
The intracellular signalling pathway activated by Wnts was originally identified as a b-catenin-dependent signalling pathway that is highly conserved among various species (He et al, 2004; Kikuchi et al, 2009 ). In the b-catenin pathway, the binding of Wnts, such as Wnt1 and Wnt3a, to a cell surface receptor complex consisting of Fz and LRP5 or LRP6 induces the stabilization of cytoplasmic b-catenin and its entry into the nucleus, where it activates the transcription factor T-cell factor (Tcf) or lymphoid enhancer factor (Lef) and stimulates the transcription of target genes. Some Wnts, such as Wnt5a and Wnt11, activate b-catenin-independent pathways that modulate cell movement and polarity (Veeman et al, 2003; Kikuchi and Yamamoto, 2008) . The b-catenin-independent pathways include multiple signalling cascades such as Rac/ Jun N-terminal kinase (JNK), Rho/Rho-associated kinase (Rho-kinase), Ca 2 þ /protein kinase C, and Ca 2 þ /calmodulindependent protein kinase II.
Wnt5a is representative of the Wnt proteins that activate the b-catenin-independent pathway, although the activation mechanism has not yet been clarified (Veeman et al, 2003; Kikuchi and Yamamoto, 2008) . Many studies on signal transduction and membrane trafficking have suggested that the sorting of signalling molecules and their receptors to different membrane-bound compartments has a critical function in regulating signalling (Conner and Schmid, 2003) . b-Arrestin mediates the internalization of the seven transmembrane receptor family in clathrin-coated pits by binding to clathrin, m2-adaptin of adaptor protein-2 (AP-2), and other elements of the endocytic machinery (Lefkowitz and Shenoy, 2005) . Wnt5a triggered the endocytosis of Fz4, which was mediated by the recruitment of Dvl2 and b-arrestin2 to the plasma membrane in HEK293 cells (Chen et al, 2003) . Wnt5a also induced the internalization of Fz5 (Kurayoshi et al, 2007) . Dvl2 interacted with AP-2, which also bound to clathrin, and this interaction was required for the internalization of Fz4 (Yu et al, 2007) . In addition, reduction of b-arrestin2 levels in Xenopus embryos led to defects in convergent extension, which is believed to be mediated by the b-catenin-independent pathway (Kim and Han, 2007; Bryja et al, 2008) . Therefore, it is possible to speculate that Wnt5a might induce the internalization of its receptors through a clathrinmediated route, thereby activating the b-catenin-independent pathway. However, there is no direct evidence for this possibility at present.
Another Wnt5a action is to inhibit the b-catenin pathway. An early experiment in Xenopus embryos showed that coexpression of XWnt5a with XWnt8 reduces the ability of XWnt8 to induce a secondary axis (Torres et al, 1996) . Several possible mechanisms have been proposed to explain this inhibition. Wnt5a was reported to inhibit the transcriptional activity of Tcf downstream of b-catenin by the phosphorylation of Tcf-4 by Nemo-like kinase (NLK) (Ishitani et al, 2003) . However, it was also reported that Wnt5a inhibits Tcf independently of the NLK pathway (Smit et al, 2004) . Another possible mechanism is that Wnt5a induced the downregulation of b-catenin through the expression of Siah2, which acts as an E3 ubiquitin ligase for b-catenin (Topol et al, 2003) . Thus, the inhibitory mechanism of the b-catenin pathway by Wnt5a remains to be clarified. In addition, it is unclear whether the internalization of receptors is involved in the Wnt5a-dependent inhibition.
In this study, it was found that Wnt5a-dependent activation of Rac requires clathrin-mediated internalization of Fz2. It was also shown that Wnt5a inhibits the b-catenin pathway by competing with Wnt3a for binding to Fz2, and that the impairment of clathrin-mediated internalization does not affect this Wnt5a inhibitory action. These results suggest that Wnt5a regulates distinct pathways through the receptor internalization-dependent and -independent mechanisms.
Results

Fz2 is involved in the activation of both b-catenindependent and -independent pathways
To identify the actions of Wnts, purified Wnt3a and Wnt5a proteins were used in all of the following experiments. First, it was determined whether which receptors mediate distinct Wnt signalling pathways. As Wnt receptors, HeLaS3 cells expressed mRNAs of Fz2, Fz5, and Fz6 and also mRNAs of LRP6, Ror1, and Ror2 (Supplementary Figure S1A and data not shown). These receptors, except for Fz5, were knocked down using small interference RNAs (siRNAs) (Supplementary Figure S1B) , because Fz5 mRNA was reduced to only 50% even though 10 different siRNAs or their combinations were used to target Fz5. Individual siRNA did not show off-target effects on the expression of other receptors (Supplementary Figure S1B) . Therefore, Fz2, Fz6, LRP6, Ror1, and Ror2 were analysed in this study.
Among the b-catenin-independent pathways, the activation of Rac was observed clearly in HeLaS3, CHO, and L cells when they were stimulated with purified Wnt5a ( Figure 1A ; Supplementary Figure S2A ). However, it was hard to detect the activation of JNK and Rho by Wnt5a and that of Rac by Wnt3a in these cells (Supplementary Figure S2B-D) . Knockdown of Fz2, Ror1, and Ror2 but not that of Fz6 or LRP6 suppressed the Wnt5a-dependent Rac activation in HeLaS3 cells ( Figure 1A ). Wnt3a, but not Wnt5a, induced the phosphorylation of LRP6 and the accumulation of b-catenin in HeLaS3, CHO, and L cells (Yamamoto et al, 2006) (Figures 1B and 4B ). Knockdown of Fz2 and LRP6 in HeLaS3 cells suppressed the Wnt3a-dependent phosphorylation of LRP6 and accumulation of b-catenin, but knockdown of Fz6, Ror1, or Ror2 did not ( Figure 1B) .
To perform the ligand-receptor binding assay, the cysteinerich domain (CRD) of Fz or the extracellular domain of LRP6 (LRP6N) fused to IgG (Fz2CRD-IgG, Fz6CRD-IgG, and LRP6N-IgG) were expressed in HEK293 cultured medium, and proteins were purified using protein A-Sepharose. Consistent with the results in Figure 1A and B, Wnt5a and Wnt3a bound to the CRD of Fz2 with K d values of 2.3 nM (90 ng/ml)±0.7 nM and 2.8 nM (112 ng/ml)±0.9 nM, respectively, and neither of them bound to the CRD of Fz6 ( Figure 1C ). Wnt5a showed a weak-binding activity with LRP6N as compared with Wnt3a ( Figure 1D ). In contrast, Wnt5a, but not Wnt3a, has been reported to bind to Ror2 (Oishi et al, 2003) . Thus, it is likely that Fz2 is involved in the activation of both b-catenin-dependent and -independent pathways.
Clathrin-dependent internalization of receptors is required for Wnt5a-dependent Rac activation
To examine whether the internalization of Fz2 is necessary for the activation of Wnt signalling pathways, the endocytic route of Fz2 was analysed. It has been reported that Wnt5a induces the internalization of Fz4 and Fz5 (Chen et al, 2003; Kurayoshi et al, 2007) . Wnt5a also induced the internalization of FLAG-tagged Fz2 (FLAG-Fz2) in HeLaS3 cells ( Figure 2A ). Approximately 45% of the internalized Fz2 was colocalized with clathrin but not with caveolin in HeLaS3 cells ( Figure 2B ). Knockdown of either Ror1 or Ror2 suppressed Wnt5a-dependent internalization of Fz2, and knockdown of both Ror1 and Ror2 further inhibited it ( Figure 2C ; Supplementary Figure S3A ). Knockdown of clathrin (Supplementary Figure S4) or treatments of the cells with monodansylcadaverine (MDC) or chlorpromazine, which suppressed the clathrin-dependent internalization of receptors, also inhibited the Wnt5a-induced internalization of Fz2 ( Figure 2D ; Supplementary Figure S3B ). Although it has been reported that the protein levels of Dvl are reduced in the cells treated with hyperosmotic sucrose and potassium depletion that suppress the clathrin-dependent internalization (Bryja et al, 2007a) , clathrin siRNA, MDC, or chlorpromazine did not affect Dvl levels (Supplementary Figure S5) . In addition, knockdown of Dvl2 and b-arrestin2 also suppressed the Wnt5a-dependent internalization of Fz2 ( Figure 2E ; Supplementary Figure S4 ). These results suggest that Wnt5a induces the internalization of Fz2 through a clathrin-mediated endocytic route and that Ror1, Ror2, Dvl2, and b-arrestin have a function in this step.
The knockdown of clathrin in HeLaS3 cells, but not that of caveolin, inhibited the Wnt5a-dependent Rac activation ( Figure 3A ; Supplementary Figures S4 and S6A) . Treatment of the cells with MDC or chlorpromazine also inhibited Wnt5a-dependent Rac activation ( Figure 3B ), whereas that with Nystatin, which disrupts the lipid raft containing caveolin, did not (Supplementary Figure S6B) . In addition, Wnt5a failed to activate Rac in Dvl2 or b-arrestin2 knockdown cells ( Figure 3C ). It has been shown that Epsin is involved in the clathrin-dependent internalization of receptors for trasnferrin, EGF, and insulin, and that clathrin-dependent internalization of these receptors is inhibited in cells expressing the ENTH domain of Epsin (Nakashima et al, 1999; Itoh et al, 2001) . As expected, the Wnt5a-dependent activation of Rac was inhibited in CHO cells expressing the ENTH domain ( Figure 3D ). These results suggest that the clathrin-dependent internalization is required for Wnt5a-dependent activation of Rac. Consistent with the results from mouse embryonic fibroblasts (MEFs) (Bryja et al, 2008) , the overexpression of b-arrestin2 in HEK293T cells activated Rac to the same extent as with Dvl2 ( Figure 3E ). Whether the activation of Rac by Dvl2 or b-arrestin2 is related with the internalization of Fz2 without Wnt5a stimulation was examined. After HeLas3 cells expressing Fz2 was kept at 41C, internalization was initiated by the shift to 371C. When Fz2 was expressed alone, Fz2 was localized to the cell surface membrane after 20-min incubation at 371C ( Figure 3F ). When Fz2 and Dvl2 were coexpressed, Dvl2 was observed at the cell surface membrane at 41C, and the expression of Dvl2 induced the internalization of Fz2 at 371C ( Figure 3F) . Moreover, the internalized Fz2 was colocalized with Dvl2 ( Figure 3F ). The expression of b-arrestin2 also induced the internalization of Fz2 without Wnt5a stimulation although b-arrestin2 was distributed throughout the cytoplasm ( Figure 3F ). Dvl2-and b-arrestin2-induced internalization of Fz2 was observed even in the presence of secreted Fz-related protein 2 (sFRP2), which binds to Wnt proteins and blocks Wnt signalling (Kawano and Kypta, 2003) (Supplementary Figure S7A) . It is notable that Dvl2-induced Rac activation was observed in Fz2 knockdown cells, whereas b-arrestin2-induced Rac activation was lost by knockdown of Fz2 (Supplementary Figure S7B) . Taken together, these results suggest that the clathrin-dependent internalization of Fz2 has a function in Wnt5a-dependent activation of Rac, and it is likely that overexpressed Dvl2 by itself has another way to activate Rac. 
Wnt5a inhibits Wnt3a-dependent accumulation of b-catenin
One of the earliest observations about Wnt5a was that it has an ability to inhibit the b-catenin pathway. As the effects of Wnt5a were analysed using artificial reporter gene assays in earlier studies (Ishitani et al, 2003; Mikels and Nusse, 2006) , this study investigated the inhibitory mechanism of the b-catenin pathway by Wnt5a by measuring target gene expression, b-catenin stability, and the phosphorylation of LRP6 at endogenous levels. Among target genes such as c-Myc, cyclinD1, Dkk1, and Axin2 in the b-catenin pathway, Wnt3a increased Axin2 mRNA levels greatly in HeLaS3, NIH3T3, and C3H10T1/2 cells ( Figure 4A ). Wnt5a did indeed suppress Wnt3a-dependent increases in Axin2 mRNA levels in these cells, and it also inhibited the Wnt3a-dependent b-catenin accumulation ( Figure 4A and B) . Furthermore, the inhibition of b-catenin accumulation by Wnt5a was observed in MKN-1, CHO, and L cells ( Figure 4B ), suggesting that Wnt5a is able to suppress the b-catenin pathway by inhibiting the accumulation of b-catenin. Wnt5a has been reported to induce the expression of Siah2, which functions as an E3 ubiquitin ligase to degrade b-catenin, in HEK293 cells (Topol et al, 2003) . However, in our hand Wnt5a did not increase Siah1 or Siah2 mRNA levels in HEK293 or HeLaS3 cells (data not shown). Although Axin2 is also known to degrade b-catenin and acts as a negative regulator of the b-catenin signalling (Yamamoto et al, 1998; Lustig et al, 2002) , Wnt5a alone did not increase Axin2 mRNA levels in contrast to Wnt3a ( Figure 4A ). After HeLaS3 cells were treated with Wnt3a for 3 h, under conditions where b-catenin accumulated maximally, Wnt3a was removed from the culture medium. The b-catenin levels reduced gradually in a time-dependent manner, but the addition of Wnt5a did not affect the b-catenin levels ( Figure 4C) . Furthermore, the accumulation of b-catenin following LiCl treatment, which acts as a GSK-3 inhibitor, or lactacystin, which functions as a proteasome inhibitor, was not suppressed by Wnt5a ( Figure 4D ). These results suggest that Wnt5a does not induce the degradation of b-catenin but is involved in the regulation of b-catenin stabilization upstream of b-catenin.
Wnt5a inhibits Wnt3a-dependent phosphorylation of LRP6
Although Wnt5a suppressed the increases in Axin2 mRNA levels induced by overexpression of Wnt3a, it did not affect the increases due to LRP6DN, a constitutively active form of LRP6, or Dvl2 in HeLaS3 cells ( Figure 5A ). Wnt3a induced the phosphorylation of LRP6 at Ser1490 and Thr1479 (Davidson et al, 2005; Zeng et al, 2005) , and Wnt5a inhibited it in HeLaS3 cells ( Figure 5B ). These findings were confirmed in NIH3T3, L, and C3H10T1/2 cells ( Figure 5C ), suggesting that Wnt5a affects the b-catenin pathway at the receptor level.
To further examine the loss of function of Wnt5a, MEFs were prepared from Wnt5a knockout (Wnt5a Figure 5D ). Wnt3a-dependent increases in Axin2 mRNA levels were enhanced in Wnt5a À/À MEFs as compared with Figure 5D ). However, increases in the levels of Axin2 mRNA following LiCl treatment were similar between Wnt5a À/À and Wnt5a þ / þ MEFs ( Figure 5D ). Furthermore, the Wnt3a-dependent phosphorylation of LRP6 at Ser1490 was enhanced in Wnt5a À/À MEFs ( Figure 5E ). These results support the findings that Wnt5a acts on the receptor to inhibit the b-catenin pathway.
The in vivo activity of the b-catenin pathway was assessed directly in the Wnt5a À/À embryos using BATlacZ transgenic mice, in which LacZ expression is under the control of eight Tcf/Lef-binding sites (Maretto et al, 2003; Nakaya et al, 2005) . It has been reported that the Wnt5a mRNA is expressed in the fronted nasal process, telencephalon, diencephalons, mesencephalon, limb buds, genital primordial, and tailbud at 9.5-12.5 d.p.c (Takada et al, 1994; Yamaguchi et al, 1999) . BATlacZ expression was clearly detected in the telencephalon, diencephalons, limb buds, and tailbud in Wnt5a þ / þ embryos at 10.5 d.p.c., which was consistent with the earlier observation (Maretto et al, 2003) . Ectopic LacZ staining was enhanced on the dorsal side of the telencephalon of Wnt5a À/À /BATlacZ mice ( Figure 5F , arrowheads), whereas otic vesicles ( Figure 5F , arrows) and other regions including the bronchial arches, limb buds, and somites (data not shown) were stained at similar levels between Wnt5a þ / þ and Wnt5a À/À embryos. Therefore, these observations suggest that the activity of the b-catenin pathway was enhanced at least in the telencephalon in vivo by removing Wnt5a.
Wnt5a competes with Wnt3a for binding to Fz2
It has been reported that overexpression of Ror2 mediates Wnt5a-dependent inhibition of the b-catenin pathway in L cells (Mikels and Nusse, 2006) . However, knockdown of Ror2 and/or Ror1 in HeLaS3 cells did not affect the Wnt5a-induced inhibition of b-catenin accumulation and Axin2 mRNA expression ( Figure 6A ). It has been proposed that Wnt3a induces the phosphorylation of LRP6 by CK1g in a Dvl-dependent manner, and the recruitment of Axin further enhances the phosphorylation of the PPPSP motifs by GSK-3 (Bilic et al, 2007; Zeng et al, 2008) . The present results also raised the possibility that Wnt5a inhibits CK1g phosphorylation of LRP6. However, Wnt5a could not affect the phosphorylation of LRP6, which was induced by overexpression of CK1g ( Figure 6B ). As shown in Figure 1 , Wnt3a and Wnt5a bound to CRD of Fz2 with a similar affinity. Therefore, one possibility for the inhibitory mechanism of the b-catenin pathway by Wnt5a is that Wnt5a may inhibit the binding of Wnt3a to Fz2. Wnt5a indeed competed with Wnt3a for binding to the CRD of Fz2 in vitro ( Figure 6C ). Wnt3a bound to Fz2 expressed in HeLaS3 cells, and Wnt5a inhibited it ( Figure 6D ). Consistent with these results, Wnt5a could not inhibit the phosphorylation of LRP6 induced by the fusion construct of Wnt8 and Fz5, which activates the b-catenin pathway ( Figure 6B ) (Holmen et al, 2005) .
Another possibility is that Wnt5a may remove Fz2 by internalizing it, thereby suppressing the Wnt3a-dependent activation of the b-catenin pathway. However, the manipulations to inhibit clathrin-dependent receptor internalization did not affect the ability of Wnt5a to inhibit the Wnt3a-dependent phosphorylation and accumulation of b-catenin (Figure 6E and F; Supplementary Figure S8) . Therefore, the clathrin-dependent internalization of receptors is not necessary for the action of Wnt5a to suppress the b-catenin pathway. Taken together, these results suggest that Wnt5a suppresses the b-catenin pathway by inhibiting the binding of Wnt3a to Fzs on the cell surface membranes.
Discussion
Wnt5a is involved in various cellular functions through the regulation of multiple signalling pathways (Veeman et al, 2003; Kikuchi and Yamamoto, 2008) . This study showed that Wnt5a activates the b-catenin-independent pathway and inhibits the b-catenin pathway by binding to Fz2, at least in HeLaS3 cells. To activate Rac, Wnt5a internalized Fz2 probably with Ror1 or Ror2 through the clathrin-mediated route, whereas Wnt5a competed with Wnt3a for binding to Fz2 to inhibit the b-catenin pathway. These results suggest that one Wnt ligand can function in two distinct pathways by binding to the same receptor through different mechanisms.
The mechanism by which Wnt5a activates the Rac pathway b-Arrestin is critical for mediating the internalization of the receptors in clathrin-coated pits by binding to clathrin, AP-2, and other elements of the endocytic machinery (Lefkowitz and Shenoy, 2005) . It has been reported that the mutation of b-arrestin2 and Dvl2, which are not able to bind to clathrin and AP-2, or antisense morpholinos for b-arrestin2 cause defects of convergent extension movement in Xenopus embryos (Kim and Han, 2007; Yu et al, 2007; Bryja et al, 2008) . In addition, the expression of Dvl2 mutants that do not bind to AP-2 prevented Wnt5a-dependent internalization of Fz4 in HEK293 cells (Yu et al, 2007) . These results suggest that the clathrin-dependent endocytic route is involved in the convergent extension movement, which is probably regulated by the b-catenin-independent pathway.
In this study, it was shown that the clathrin-mediated internalization of Wnt receptors, at least Fz2, is involved in Wnt5a-dependent Rac activation. This conclusion was based on the following findings. First, Wnt5a induced the internalization of Fz2 in a clathrin-mediated route. Second, the þ / þ and Wnt5a À/À embryos were stained with X-gal to detect BATlacZ reporter activity at E10.5. Embryos are shown in anterior view. In the telencephalon, b-galactosidase activity of Wnt5a À/À embryo was stronger than that of Wnt5a þ / þ (arrowheads). The staining in otic vesicles (arrows) and other regions showed similar staining intensity between Wnt5a þ / þ and Wnt5a À/À embryos. (D) HeLaS3 cells expressing FLAG-Fz2 were incubated with 300 ng/ml Wnt3a for 1 h in the presence of the indicated concentrations of Wnt5a, and then cell lysates were immunoprecipitated with anti-FLAG antibody. The precipitates were probed with anti-Wnt3a, anti-Wnt5a, and anti-FLAG antibodies. The signals of Wnt3a bound to FLAG-Fz2 were quantified using NIH Image and expressed as arbitrary units. The results shown are representative of three independent experiments. (E) HeLaS3 cells transfected with control or clathrin siRNA were treated with 100 ng/ml Wnt3a with or without 300 ng/ml Wnt5a for 1 h. The lysates were probed with the indicated antibodies. The signals of b-catenin and S1490P were quantified using NIH Image. The results are expressed as arbitrary units compared with the signal intensities in control cells with Wnt3a stimulation, and indicate means ± s.e. from four independent experiments. (F) CHO cells or CHO cells expressing Myc-ENTH were treated with 100 ng/ml Wnt3a with or without 300 ng/ml Wnt5a for 1 h. The lysates were probed with the indicated antibodies. The signals of b-catenin and S1490P were quantified using NIH Image.
impairment of clathrin-dependent internalization of receptors inhibited Wnt5a-induced Rac activation. Third, the expression of b-arrestin2 or Dvl2 induced the internalization of Fz2 and activation of Rac. Ror1 and Ror2 are known to mediate the b-catenin-independent pathway (Green et al, 2008) . Consistent with this, knockdown of Ror1 and/or Ror2 reduced Wnt5a-dependent activation of Rac and internalization of Fz2. It was hard to see the internalization of Ror2, because the expression of Ror2 induces morphological changes when Wnt5a was added to the cells (data not shown). The caveolindependent internalization of LRP6 and Fz5 in response to Wnt3a has been demonstrated to be necessary for activation of the b-catenin pathway (Yamamoto et al, 2006 . Therefore, by the analogy with the case of Wnt3a and LRP6, Ror1 or Ror2 may be internalized in response to Wnt5a. It is intriguing to speculate that the different endocytic routes in response to specific Wnts determine the activation of either the b-catenin-dependent or -independent pathway in addition to the combination of Fz and a singlepass transmembrane receptor such as LRP6, Ror1, or Ror2 with Wnts. How the internalization of Wnt receptors triggers the activation of the pathway is unclear. It is known that b-arrestin serves as a scaffold linking seven transmembrane receptors to other signalling proteins, such as the src-family kinases and members of the mitogen-activated protein kinase cascade (Perry and Lefkowitz, 2002) . It is possible that the clathrin-dependent internalization of Wnt5a receptors induces the recruitment of GDP/GTP exchange factor of Rac to Dvl through b-arrestin, thereby activating Rac. The Wnt3a-dependent accumulation of b-catenin was inhibited in b-arrestin2 knockout MEFs, and b-arrestin2 bound to Axin that functions in the degradation of b-catenin (Bryja et al, 2007b) . Therefore, b-arrestin may act as a scaffold protein to regulate both the b-catenin-dependent and -independent pathways. It has also been reported that clathrin-and Rab5-mediated endocytic route is required for the activation of Rac induced by epidermal growth factor and hepatocyte growth factor (Palamidessi et al, 2008) . In this scenario, Rac is activated on early endosomes, where Tiam1 (one of GDP/GTP exchange factor of Rac) is recruited. It is intriguing to speculate that Wnt5a receptors traffic to early endosomes in a Rab5-dependent manner and then Rac is activated.
The mechanism by which Wnt5a inhibits the b-catenin pathway It was shown that the activity of the b-catenin pathway is enhanced in the telencephalon in Wnt5a À/À mouse embryos.
These findings were consistent with the observations that b-catenin is accumulated in the limb buds of Wnt5a À/À embryos and in pipetail (Wnt5a) knockout zebrafish embryos (Topol et al, 2003; Westfall et al, 2003) . Therefore, Wnt5a suppresses the b-catenin pathway in vivo. Concerning the inhibitory mechanism by Wnt5a, it has already been reported that Wnt5a inhibits the b-catenin pathway by suppressing the formation of b-catenin and Tcf complex or by inducing Siah2-dependent b-catenin degradation (Ishitani et al, 2003; Topol et al, 2003) . These results suggested that Wnt5a acts on b-catenin itself or downstream of b-catenin. However, this study showed that Wnt5a inhibits the Wnt3a-dependent phosphorylation of LRP6, accumulation of b-catenin, and increases in Axin2 mRNA at endogenous levels in several cultured cell lines. It was also shown that Wnt5a affects neither LRP6DN-or Dvl2-dependent Axin2 mRNA increases nor LiCl-or lactacystin-induced b-catenin accumulation at least in HeLaS3 cells. Furthermore, Wnt3a-dependent LRP6 phosphorylation was enhanced in Wnt5a À/À MEFs. These results suggest that Wnt5a acts upstream of b-catenin, probably at the receptor level. Wnt5a competed with Wnt3a for binding to both the CRD of Fz2 in vitro and the full length of Fz2 expressed in intact cells. Fz2 was required for the Wnt3a-dependent phosphorylation of LRP6 and accumulation of b-catenin. In addition, the clathrindependent internalization was not required for the inhibitory action of Wnt5a. Taken together, Wnt5a could inhibit the b-catenin pathway by titrating Fz2 from Wnt3a activating the b-catenin pathway on the cell surface membrane.
The discrepancy between earlier observations and the present results in the inhibitory mechanism by Wnt5a may be due to assay conditions. The results in earlier studies were obtained from experiments with the transfection of Wnt ligands and/or reporter gene constructs such as TOPFLASH. We showed earlier that Wnt5a inhibits the transcriptional activity of Tcf downstream of b-catenin in HEK293 cells (Kurayoshi et al, 2007) as reported by other groups (Ishitani et al, 2003; Mikels and Nusse, 2006) . Knockdown of clathrin suppressed Wnt5a-dependent inhibition of Tcf-4 activity activated by a constitutively active form of b-catenin (SA-b-cat) (Supplementary Figure S9) . Thus, some intracellular signal transduction pathways activated by Wnt5a may inhibit the transcription activated by b-catenin in the nucleus of HEK293 cells, and this inhibition may require the clathrin-dependent internalization. Therefore, the inhibitory mechanism by Wnt5a may depend on the cell type. At present, it is conceivable that Wnt5a can interfere with different steps of the b-catenin pathway.
The mechanism by which Wnt determines the specificity of signalling pathway How do Wnt3a and Wnt5a regulate different pathways by binding to the same receptor such as Fz2? The distribution of receptors in the lipid raft or non-lipid raft microdomains could be important for the selective regulation of the signalling pathways by different Wnts. For instance, Fz2, Fz5, and LRP6 were located to both the lipid raft and non-lipid raft domains (Yamamoto et al, 2006) (Supplementary Figure S10) .
When cells expressing FLAG-Fz2 alone were stimulated with Wnt3a, FLAG-Fz2 was internalized and colocalized with clathrin mainly (Supplementary Figure S11A) . However, when cells coexpressing FLAG-Fz2 and LRP6-GFP were stimulated with Wnt3a, the internalized receptor complex was colocalized with caveolin mainly (Supplementary Figure  S11B) . Therefore, Wnt3a may induce the internalization of Fz2 through a clathrin-mediated pathway probably with Ror1 or Ror2, and when both Fz2 and LRP6 are activated by Wnt3a, the complex may be internalized through the caveolin-mediated pathway. These results support our data that Wnt3a activates both the b-catenin and Rho (PCP) pathways (Kishida et al, 2004) and are consistent with our earlier observations using FLAG-Fz5 (Yamamoto et al, 2006) . In contrast, when cells coexpressing FLAG-Fz2 and LRP6-GFP were stimulated with Wnt5a, FLAG-Fz2 was internalized and colocalized with clathrin mainly, whereas LRP6-GFP remained on the cell surface membrane (Supplementary Figure S12) . In addition, it is notable that the numbers of Fz2 puncta internalized by Wnt5a decreased when Fz2 and LRP6 were coexpressed as compared with that when Fz2 was expressed alone (see Figure 2B ). This suggests that the coexpression of LRP6 causes unknown effects to lead to the retention of Fz2 on the cell surface membrane when the cells were stimulated with Wnt5a that had low affinity for LRP6. The overexpression of LRP6 might influence the circumstance of Fz2 and affect the Wnt5a-mediated internalization of Fz2 in the non-lipid raft. It is unlikely that Wnt5a induces the internalization of LRP6 with Fz2 through a caveolinmediated route at least in HeLaS3 cells. Taken together, it is conceivable that the endocytic routes of and the signalling pathways activated by Fz2 are determined by the combination of distinct Wnt ligands and single-pass transmembrane receptors.
Although the experiments with Fz5 knockdown could not be performed due to poor efficiency in this study, it was reported that Fz5 functions as a receptor for both Wnt3a and Wnt5a (He et al, 1997; Kurayoshi et al, 2007; Pan et al, 2008) . Wnt3a and Wnt5a also had similar affinities for CRDs of Fz5 and Fz2 in vitro (Supplementary Figure S13) . Wnt3a still induced the phosphorylation of LRP6 in Fz2 knockdown cells, suggesting that other Fzs including Fz5 act as receptors for Wnt3a/b-catenin signalling. Knockdown of Fz2 suppressed Wnt5a-dependent Rac activation completely in HeLaS3 cells. Therefore, it is unlikely that Fz5 mediates Wnt5a-dependent Rac activation in this cell line. It might be possible that Fz5 functions depending on the ligand and signalling context.
The possible model to explain how Wnt determines the specificity of signalling pathway is as follows (Figure 7) . When Wnt3a interacts with Fz and LRP6 simultaneously in the lipid raft microdomain, it activates the b-catenin pathway through the caveolin-mediated internalization route (Yamamoto et al, 2006) . When Wnt3a binds to Fz in the non-lipid raft, Wnt3a may activate the b-catenin-independent pathway through the clathrin-dependent internalization route probably with Ror1 or Ror2. Dkk1 removes LRP6 from the lipid raft to the non-lipid raft, and internalizes LRP6 through a clathrin-dependent route, thereby inhibiting the b-catenin pathway . When Wnt5a acts on Fz and Ror1 or Ror2 in the non-lipid raft domain, it may induce the clathrin-dependent internalization of Fz with Ror1 or Ror2, thereby activating the b-catenin-independent pathway. When Wnt5a acts on Fz that can activate the b-catenin pathway in the lipid raft domain, it may compete with Wnt3a, thereby inhibiting the b-catenin pathway. Thus, Wnt5a and Wnt3a may regulate the b-catenin-dependent and -independent pathways by differences in the specificity and in the internalization of receptors.
The following observations are different from our results, and these issues should be addressed. It has been reported that Wnt5a induces axis duplication in Xenopus embryos overexpressing Fz5 (He et al, 1997) and stabilized b-catenin in HEK293 cells overexpressing Fz4 and LRP5 (Mikels and Nusse, 2006) , suggesting that Wnt5a can activate the b-catenin pathways. However, as far as we examined in 10 different cultured cells expressing at least one of Fz2, Fz4, or Fz5 and LRP6 endogenously, the stabilization of b-catenin by Wnt5a was not observed. In addition, although Wnt5a bound to Fz2 with an affinity similar to Wnt3a, it showed less affinity to LRP6 than Wnt3a. Therefore, it is conceivable that Wnt5a is able to activate the b-catenin pathway under conditions of the overexpression of certain receptors. It has also been shown that Wnt3a conditioned medium and overexpression of Wnt3a activate Rac in ST2 and HEK293 cells (Habas et al, 2003; Wu et al, 2008) . Therefore, whether Wnt3a activates Rac may be dependent on cell types. Alternatively, other factor(s) in addition to Wnt3a might be β-Catenin Possible mechanism by which Wnt determines the specificity of signalling pathway. When Wnt3a interacts with Fz and LRP6 simultaneously in the lipid raft microdomain, it activated the b-catenin pathway through the caveolin-mediated internalization route. Wnt3a may activate the b-catenin-independent pathway through the clathrin-dependent internalization route. Dkk1 removes LRP6 from the lipid raft to the non-lipid raft, and internalized LRP6 through a clathrin-dependent route, thereby inhibiting the b-catenin pathway. When Wnt5a acts on Fz and Ror1 or Ror2 in the non-lipid raft domain, it may induce the clathrin-dependent internalization of Fz probably with Ror1 or Ror2, thereby activating the b-catenin-independent pathway. When Wnt5a acts on Fz that can activate the b-catenin pathway in the lipid raft domain, it may compete with Wnt3a, thereby inhibiting the b-catenin pathway. Black boxes indicate Wnt5a actions, which were revealed in this study.
necessary for the activation of Rac. Furthermore, another model is that LRP6 inhibits the b-catenin-independent pathway by binding to Wnt5a (Bryja et al, 2009) . It was also shown that the phenotypes by deletion of LRP6 in mice and Xenopus embryos are rescued by additional deletion of Wnt5a. These are interesting findings, but at present it is difficult to conclude that these phenotypes are due to LRP6-dependent suppression of the b-catenin-independent pathway. Further studies will be necessary for the understandings of selective activation mechanisms of Wnt signalling pathways.
